From today the shares of Pledpharma are being traded on Nasdaq Stockholm main market. As we have mentioned previously, we believe this is long-term positive for the stock, as Nasdaq Stockholm attracts more attention from domestic and international investors with its tighter requirements of international accounting and information standards. We do see growing momentum in the share, and the stock now trades at its 3 months high. We reiterate our base case of SEK 50.